Literature DB >> 11416645

Genes for Essential Hypertension: Hype, Help, or Hope?

Bonnie Thiel1, Alan B. Weder.   

Abstract

Identification of genetic variation predisposing to high blood pressure is an active area of research. Characterization of genes for hypertension may permit focused efforts at primary prevention, may predict responses to pharmacologic interventions, and may identify individuals at risk for target organ damage. To date, genes for several rare types of hypertension have been identified, but such genes appear to play no important role in essential hypertension. Variants of the genes encoding the elements of the renin-angiotensin system have been extensively studied, with inconsistent results. It appears that such variants account for only a small part of blood pressure variation but may identify individuals at risk for blood pressure salt-sensitivity. Further successes in finding genes for hypertension will result from advances in genotyping, improved characterization of environmental factors impacting on genotype variation, and longitudinal studies of the evolution of pre-hypertension to hypertension. (c)2000 by Le Jacq Communications, Inc.

Entities:  

Year:  2000        PMID: 11416645

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  3 in total

1.  Angiotensin Converting Enzyme Gene Polymorphism and its Association with Hypertension in South Indian Population.

Authors:  Ipsita Choudhury; R Jothimalar; Arun Kumar Patra
Journal:  Indian J Clin Biochem       Date:  2012-05-05

2.  Polymorphisms of the insertion / deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data.

Authors:  Adrian Mondry; Marie Loh; Pengbo Liu; Ai-Ling Zhu; Mato Nagel
Journal:  BMC Nephrol       Date:  2005-01-11       Impact factor: 2.388

Review 3.  The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression.

Authors:  William C Cushman
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 May-Jun       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.